Rhythm Pharma shares fall as obesity drug trial fails to meet main goal
Source link
Rhythm Pharma shares fall as obesity drug trial fails to meet main goal
Source link
Finizer is an educational platform and not a SEBI-registered investment advisory service. All content is for learning purposes only. Financial markets involve risk, and education is the foundation of responsible participation.